CD274 and Hodgkins lymphoma: It regulates the inhibitory ligands upon immune cell activation via direct binding of the promotor region, e.g., as observed in Hodgkin’s lymphoma by the binding of Jun to the enhancer region of the PD-L1 promoter, resulting in PD-L1 expression [165,166].